Skip to content

Clinical trials

Phase 3 Cardiovascular Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 3 Country / region: China Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20053
20071
20082
20091
20101
20111
20122
20131
20151
20182
20193
20232
20241
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Recruiting6
Terminated5
Active, not recruiting4
Enrolling by invitation2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
GlaxoSmithKline3
AstraZeneca2
United Therapeutics2
Adelaide Institute for Sleep Health1
Alnylam Pharmaceuticals1
Amgen1
Boehringer Ingelheim1
Chinese University of Hong Kong1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases29
Stroke8
Myocardial Infarction6
Hypertension5
Vascular Diseases5
Atherosclerosis4
Cerebrovascular Disorders4
Dyslipidemias4
Hypercholesterolemia4
Hyperlipidemias4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.